SMTL ID : 5hi4.1

Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

hetero-2-2-2-1-mer

Ligands

1 x 63P: (9'S,17'R)-6'-chloro-N-methyl-9'-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-10',19'-dioxo-2'-oxa-11',18'-diazaspiro[cyclopentane-1,21'-tetracyclo[20.2.2.2~12,15~.1~3,7~]nonacosane]-1'(24'),3'(29'),4',6',12',14',22',25',27'-nonaene-17'-carboxamide(Non-covalent)

63P.1: 19 residues within 4Å: Chain A: Y.62, P.63, V.65, I.66, W.67, E.95, I.96, L.97, V.98, L.99, L.112 Chain B: P.63, I.66, Q.94, E.95, I.96, L.97, V.98, K.114 14 PLIP interactions: 8 interactions with chain B, 6 interactions with chain A Hydrophobic interactions: B:I.96, B:I.96, B:L.97, B:L.97, B:K.114, A:Y.62, A:Y.62, A:I.96 Hydrogen bonds: B:L.97, B:L.97, A:W.67, A:L.97, A:L.97 Water bridges: B:Q.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, S. et al., Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists. Sci Rep (2016)

Release Date

2016-08-31

Peptides

Interleukin-17A: AB
CAT-2000 FAB heavy chain: CE
CAT-2000 FAB light chain: DG
synthetic IL-17A peptide inhibitor: F

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

E
H

D
D

G
L

F
I

Interleukin-17A

CAT-2000 FAB heavy chain

CAT-2000 FAB light chain

synthetic IL-17A peptide inhibitor

Related Entries With Identical Sequence